Goldman Sachs
ARAV

Goldman Sachs’s Aravive, Inc. Common Stock ARAV Stock Holding History

Goldman Sachs’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,809
Closed -$21.2K – 5972
2023
Q2 		$21.2K Sell
16,809
-44,069
-72% -$71.5K ﹤0.01% 5540
2023
Q1 		$122K Buy
+60,878
New +$114K ﹤0.01% 5422
2022
Q3 		– Sell
-11,248
Closed -$11K – 6661
2022
Q2 		$11K Buy
+11,248
New +$14.8K ﹤0.01% 6255
2021
Q2 		– Sell
-13,168
Closed -$87K – 6609
2021
Q1 		$87K Sell
13,168
-197
-1% -$1.29K ﹤0.01% 5869
2020
Q4 		$75K Sell
13,365
-7,635
-36% -$41.9K ﹤0.01% 5332
2020
Q3 		$99K Sell
21,000
-1,939
-8% -$13.8K ﹤0.01% 5096
2020
Q2 		$267K Buy
+22,939
New +$272K ﹤0.01% 4682
2018
Q4 		– Sell
-32,625
Closed -$274K – 5785
2018
Q3 		$274K Sell
32,625
-22,052
-40% -$232K ﹤0.01% 4763
2018
Q2 		$664K Buy
54,677
+17,306
+46% +$178K ﹤0.01% 4343
2018
Q1 		$370K Sell
37,371
-11,946
-24% -$134K ﹤0.01% 4672
2017
Q4 		$651K Buy
49,317
+38,643
+362% +$498K ﹤0.01% 4620
2017
Q3 		$157K Sell
10,674
-6,500
-38% -$656K ﹤0.01% 5887
2017
Q2 		$1.8M Buy
17,174
+377
+2% +$40.5K ﹤0.01% 3925
2017
Q1 		$2.15M Buy
16,797
+1,778
+12% +$187K ﹤0.01% 3676
2016
Q4 		$1.34M Buy
15,019
+4,266
+40% +$323K ﹤0.01% 4201
2016
Q3 		$790K Buy
10,753
+7,283
+210% +$526K ﹤0.01% 4627
2016
Q2 		$230K Buy
+3,470
New +$197K ﹤0.01% 5582
2016
Q1 		– Sell
-3,571
Closed -$265K – 7375
2015
Q4 		$265K Buy
3,571
+857
+32% +$57.5K ﹤0.01% 5462
2015
Q3 		$188K Sell
2,714
-148
-5% -$13.9K ﹤0.01% 6058
2015
Q2 		$261K Buy
2,862
+979
+52% +$99.2K ﹤0.01% 5886
2015
Q1 		$208K Sell
1,883
-30,818
-94% -$3.62M ﹤0.01% 5982
2014
Q4 		$4.41M Sell
32,701
-168
-0.5% -$19.6K ﹤0.01% 3116
2014
Q3 		$3.75M Sell
32,869
-2,371
-7% -$314K ﹤0.01% 3310
2014
Q2 		$5.93M Buy
+35,240
New +$6.08M ﹤0.01% 2852

Other funds holding ARAV

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs's ARAV Position: Q3 2023 in Review

Goldman Sachs sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2023, closing a stake of 16,809 shares — an estimated $21.2K sold.

Goldman Sachs first reported a position in ARAV in Q2 2014 and held it in 24 quarters. The position peaked at $5.93M in Q2 2014. 33 funds tracked by Wall St. Rank hold ARAV as of Q3 2023.

  • Goldman Sachs reported no remaining Aravive, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Goldman Sachs sold 16,809 Aravive, Inc. Common Stock shares in Q3 2023, an estimated $21.2K.
  • Goldman Sachs first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 24 quarters.
  • Goldman Sachs's Aravive, Inc. Common Stock position peaked at $5.93M in Q2 2014.
  • 33 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.